FAABORG PHARMA A/S — Credit Rating and Financial Key Figures

FAABORG PHARMA A/S (CVR number: 26190770) is a company from FAABORG-MIDTFYN. The company recorded a gross profit of 10.9 mDKK in 2024. The operating profit was 2535 kDKK, while net earnings were 1762.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was 12.8 %, which can be considered good but Return on Equity (ROE) was 19.9 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 42.7 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. FAABORG PHARMA A/S's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.